Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

CUSIP: 87184Q107

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
27,995,500
Total 13F shares
44,878,307
Share change
+2,712,740
Total reported value
$265,481,374
Price per share
$5.93
Number of holders
63
Value change
+$15,181,069
Number of buys
32
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q1 2020

As of 31 Mar 2020, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,878,307 shares. The largest 10 holders included FMR LLC, ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ARCH VENTURE CORP, Flagship Pioneering Inc., BlackRock Inc., Point72 Asset Management, L.P., VANGUARD GROUP INC, and Samsara BioCapital, LLC. This page lists 63 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.